Are Shares Criminally Undervalued At GlaxoSmithKline Plc, Aberdeen Asset Management Plc & International Consolidated Airlines Group SA?

Are there bargains to be found at GlaxoSmithKline Plc (LON: GSK), Aberdeen Asset Management Plc (LON: ADN) and International Consolidated Airlines Group SA (LON: IAG)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Low valuations combined with dividends have always been the value-hunter’s greatest dream. With price/earnings ratios below 11 and regular dividends, is the market undervaluing GlaxoSmithKline (LSE: GSK), Aberdeen Asset Management (LSE: ADN) and International Consolidated Airlines Group (LSE: IAG)?

Dividend cut ahead?

Emerging markets-focused asset manager Aberdeen has suffered 11 straight quarters of withdrawals due to poorly performing funds and the meltdown in developing economies. Plummeting share prices mean the company now offers an 8% yield and a P/E ratio of 11. While investors may find these numbers hard to resist, there could be worse to come for shares.

Earnings are expected to collapse by more than a third this year, which will barely cover dividend payouts. If major institutional clients continue fleeing Aberdeen’s funds, a dividend cut becomes very likely. And with any turnaround in market sentiment towards developing economies out of sight, I’m happy to sit on the sidelines and wait for a turnaround before plonking my money into shares.

Safe play

Pharmaceuticals giant GSK certainly appears to fit the bill of a bargain share, trading at a P/E of eight and offering a 5.8% yielding dividend. Unfortunately, this eye-catching valuation is due to one-off profits received from an asset swap deal with Novartis. GSK’s 2016 forecast P/E is a more reasonable 16 times earnings.

Despite this higher valuation, GSK could still be an attractive opportunity for investors. Management has shifted focus from being a pureplay drugs manufacturer to having a more diversified portfolio of drugs, consumer healthcare goods, and vaccines. The healthcare segment and vaccines now account for 26% and 16% of revenue, respectively, providing less lumpy revenue streams year-after-year.

The traditional pharmaceuticals division will still be there to provide growth for GSK, with the most promising option being a series of new HIV treatments. HIV treatments already contribute 29% of profits, and this number is expected to continue growing as GSK gains market share. Earnings are expected to grow 12% next year, and increase from there. A once-again-safely-covered dividend and growth potential make me think that GSK could be a relatively safe play for income-hungry investors going forward.

Proving us all wrong

The parent of British Airways and Iberia, IAG, has been proving wrong the long-held sentiment that airline shares were good for little more than losing your money. Share prices are up 145% over the past five years and yet the shares trade at a mere 6.7 times forward earnings. This low valuation and a 3.5% dividend pencilled-in for 2016 will surely have value investors eagerly adding the shares to their watch lists.

While plummeting oil prices have played their part, increased efficiency at both BA and Iberia have been the largest drivers of growth. In fact, fuel prices for the company fell only 6.3% last year while profits rose a full 51%. If the company were only doing well thanks to historically low oil prices, I would be wary of the shares. However, with the company expanding astutely only on high-margin routes and buying up stakes in turnaround carriers such as Aer Lingus, IAG does have the potential to break the mould and be an airline that actually provides high shareholder returns.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ian Pierce has no position in any shares mentioned. The Motley Fool UK has recommended Aberdeen Asset Management and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman holding up three fingers
Investing Articles

New to investing? I wish I’d known these 3 things Warren Buffett swears by

Ben McPoland considers three Warren Buffett lessons that have helped his investing returns improve a lot over the last few…

Read more »

Investing Articles

I remain bullish on Nvidia stock despite its overvaluation

Our author says Nvidia stock is overvalued right now. However, he still thinks it might be worth him buying because…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

I’d take the Warren Buffett approach to building a passive income empire

Christopher Ruane explains how he'd try to earn passive income streams from the stock market by learning from billionaire investor…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

2 of my most amazing buys from the FTSE 100 for passive income

The FTSE 100's home to a number of exceptional shares offering the prospect of handsome income. Here are two to…

Read more »

Investing Articles

1 AI stock to buy and hold for 10 years

AI spending's expected to soar in the next decade, according to most experts. Here's one stock to consider buying to…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

Dividend deals! 2 passive income stocks that still look undervalued

Royston Wild explains why these FTSE 250 passive income stocks might STILL be too cheap to miss, despite theirrecent price…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Is BT Group one of the FTSE 100’s greatest value shares?

BT's share price looks like a bargain when you look at the P/E ratio and dividend yield. Is it one…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

The National Grid share price just plunged another 10%. Time to buy?

The National Grid share price is one of the FTSE 100's most stable, and nothing much happens to it? Well,…

Read more »